Congress Park Capital LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 196 filers reported holding HERON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.4%.

Quarter-by-quarter ownership
Congress Park Capital LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$606,825
+2.3%
589,150
+15.2%
0.32%
+6.8%
Q2 2023$593,050
+22.5%
511,250
+59.4%
0.30%
+17.5%
Q1 2023$484,197
-25.5%
320,660
+23.3%
0.25%
-33.9%
Q4 2022$650,275
-9.8%
260,110
+52.3%
0.38%
-8.6%
Q3 2022$721,000
+61.3%
170,760
+6.6%
0.42%
+53.3%
Q2 2022$447,000
-38.9%
160,260
+25.5%
0.27%
-25.9%
Q1 2022$731,000
-10.6%
127,748
+42.5%
0.37%
-8.9%
Q4 2021$818,000
-36.1%
89,617
-25.1%
0.40%
-38.5%
Q3 2021$1,280,000
-58.0%
119,727
-39.1%
0.66%
-57.1%
Q2 2021$3,049,000
-2.4%
196,487
+2.0%
1.53%
-12.5%
Q1 2021$3,123,000
-25.4%
192,647
-2.7%
1.74%
-29.7%
Q4 2020$4,189,000
+38.0%
197,917
-3.4%
2.48%
+32.0%
Q3 2020$3,036,000
+3.0%
204,849
+2.2%
1.88%
-16.9%
Q2 2020$2,947,000
+125.7%
200,364
+80.1%
2.26%
+92.0%
Q1 2020$1,306,000
-51.0%
111,245
-1.9%
1.18%
-40.0%
Q4 2019$2,663,000
+29.4%
113,345
+1.9%
1.96%
+13.7%
Q3 2019$2,058,000
+5.8%
111,265
+1.5%
1.73%
+12.3%
Q2 2019$1,945,000
+56.5%
109,665
+115.6%
1.54%
+43.2%
Q1 2019$1,243,000
+2.9%
50,875
+9.2%
1.07%
-19.2%
Q4 2018$1,208,000
+8.3%
46,575
+32.2%
1.33%
+32.9%
Q3 2018$1,115,000
-18.7%
35,225
-0.3%
1.00%
-23.9%
Q2 2018$1,372,000
+26.7%
35,325
-9.9%
1.32%
+18.2%
Q1 2018$1,083,000
+28.3%
39,225
-15.9%
1.11%
+30.9%
Q4 2017$844,00046,6250.85%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders